These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17907112)

  • 1. Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK.
    Parikh SV; Abdullah SM; Keeley EC; Cigarroa JE; Addo TA; Warner JJ; Khera A; de Lemos JA; McGuire DK
    Diab Vasc Dis Res; 2007 Sep; 4(3):222-5. PubMed ID: 17907112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
    JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
    Rasoul S; Ottervanger JP; Timmer JR; Svilaas T; Henriques JP; Dambrink JH; van der Horst IC; Zijlstra F
    Int J Cardiol; 2007 Oct; 122(1):52-5. PubMed ID: 17223212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.
    van der Horst IC; De Luca G; Ottervanger JP; de Boer MJ; Hoorntje JC; Suryapranata H; Dambrink JH; Gosselink AT; Zijlstra F; van 't Hof AW
    Am Heart J; 2005 Jun; 149(6):1135. PubMed ID: 15976800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
    Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.
    Chaudhuri A; Janicke D; Wilson M; Ghanim H; Wilding GE; Aljada A; Dandona P
    Am J Cardiol; 2007 Dec; 100(11):1614-8. PubMed ID: 18036357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative N-terminal pro-brain natriuretic peptide level in coronary artery bypass surgery with ventricular dysfunction after perioperative glucose-insulin-potassium treatment.
    Foroughi M; Rahimian H; Dabbagh A; Majidi M; Hekmat M; Beheshti M; Shahzamani M
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):631-6. PubMed ID: 22285123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.
    Krljanac G; Vasiljević Z; Radovanović M; Stanković G; Milić N; Stefanović B; Kostić J; Mitrović P; Radovanović N; Dragović M; Marinković J; Karadzić A
    Am J Cardiol; 2005 Oct; 96(8):1053-8. PubMed ID: 16214437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
    Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
    Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of N-terminal pro-brain natriuretic peptide in ST-segment elevation myocardial infarction: experience from a tertiary centre in India.
    Govind SC; Kiotsekoglou A; Gadiyaram VK; Gopal AS; Brodin LÅ; Ramesh SS; Saha SK
    Crit Pathw Cardiol; 2011 Dec; 10(4):180-4. PubMed ID: 22089274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
    van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
    Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.